Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Andes virus vaccine (SET Technology)
- Development stage
- Preclinical
- Lead developer
- SET Technology
- Modality
- DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Prophylactic Vaccines → Vaccines & Immunotherapeutics, RNA Therapeutics → Nucleic Acid Therapeutics
- Administration
- Intramuscular
01
Overview
The Andes virus vaccine is a DNA/RNA-based prophylactic candidate being developed by SET Technology for the prevention of Andes virus infection. Andes virus is a member of the hantavirus family and is a primary causative agent of Hantavirus Pulmonary Syndrome (HPS), particularly in South America. The vaccine utilizes SET Technology's proprietary platform to deliver genetic material (DNA or RNA) encoding specific viral antigens into host cells. This process is intended to trigger the host's immune system to produce a protective response, including the generation of neutralizing antibodies and T-cell activation, to prevent subsequent infection by the virus. As of early 2024, the vaccine is in the optimization stage of preclinical development.
- Other names
- Andes Virus Vaccine
Beyond the preview
Go deeper on Andes virus vaccine (SET Technology).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Andes virus vaccine (SET Technology).